MarketBeat on MSN12d
Is Tonix Pharmaceuticals the Next Biotech Breakout?Clinical-stage biopharmaceutical company Tonix Pharmaceuticals (NASDAQ: TNXP) is gaining significant attention from investors ...
Stocktwits on MSN6d
Tonix Pharma Dominates Retail Biotech Buzz After 1-for-100 Reverse Split, Sentiment Turns Neutral Amid VolatilityTonix Pharmaceuticals saw its shares swing wildly between gains and losses on Wednesday morning as they started to trade ...
GlobalData on MSN4d
Tonix Pharmaceuticals reports positive topline trial outcomes of TNX-1500Tonix Pharmaceuticals has reported positive topline outcomes from its Phase I single ascending dose study of its ...
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products ...
Tonix shares are moving higher on Friday after the company provided preliminary 2024 fiscal-year financial results.
Company had $98.8 million in cash as of December 31, 2024; existing cash expected to fund planned operations into the first quarter of ...
Tonix Pharmaceuticals (TNXP) stock jumped 11% Friday after the company issued a business update along with a preliminary 2024 ...
EST Tonix Pharmaceuticals (TNXP) trading halted, news pendingMaximize Your Portfolio with Data Driven Insights:Leverage the power of ...
Clinical-stage biopharmaceutical company Tonix Pharmaceuticals (NASDAQ: TNXP) is gaining significant attention from investors and market participants. The company develops therapies for conditions ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback